Medpace rises after lifting 2025 revenue forecast

Shares of contract research organization Medpace MEDP.O rise 42.5% to $440 premarket

Co late on Monday, forecasted 2025 revenue in the range of $2.42 billion to $2.52 billion compared to previous expectation of $2.14 billion to $2.24 billion

Analysts were expecting 2025 sales to be $2.19 billion as per LSEG data

Co reported Q2 revenue of $603.3 mln beating analysts' estimates of $538.8 mln as per LSEG data

Co reported Q2 net income of $3.10 per share vs $2.75 per share a year ago

Up to last close, stock down 7% YTD